The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; AstraZeneca; Daiichi Sankyo; Eisai; Novartis; Pfizer; Roche; Tesaro; Teva
Consulting or Advisory Role - Amgen; Daiichi Sankyo; Eisai; Hexal; Nektar; Roche
Travel, Accommodations, Expenses - Pfizer; Roche
Germline mutation status and therapy response in high-risk early breast cancer: Results of the GeparOcto study (NCT02125344).
 
Esther Pohl-Rescigno
No Relationships to Disclose
 
Jan Hauke
No Relationships to Disclose
 
Kerstin Rhiem
Consulting or Advisory Role - Tesaro
Travel, Accommodations, Expenses - AstraZeneca
 
Volker Möbus
Honoraria - Amgen; AstraZeneca; Celgene; Myelo Therapeutics GmbH; Roche Pharma AG
Consulting or Advisory Role - Amgen; Myelo Therapeutics GmbH; Roche Pharma AG
 
Jenny Furlanetto
No Relationships to Disclose
 
Carsten Denkert
Stock and Other Ownership Interests - Sividon Diagnostics
Honoraria - Amgen; AstraZeneca; Celgene; Daiichi Sankyo; MSD; Novartis; Pfizer; Roche; Teva
Patents, Royalties, Other Intellectual Property - EP18209672
Other Relationship - VMscope
 
Peter A. Fasching
Honoraria - Amgen; AstraZeneca; Celgene; Daiichi Sankyo; Eisai; Hexal; Merck Sharp & Dohme; Myelo Therapeutics GmbH; Novartis; Pfizer; Puma Biotechnology; Roche; Teva
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Daiichi Sankyo; Eisai; Hexal; Merck Sharp & Dohme; Myelo Therapeutics GmbH; Novartis; Pfizer; Puma Biotechnology; Roche; Teva
Research Funding - BioNTech (Inst); Novartis (Inst)
 
Claus Hanusch
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Novartis; Pfizer; Roche
Speakers' Bureau - Celgene; Lilly; Novartis; Pfizer; Roche
 
Hans Tesch
Honoraria - Novartis; Roche
Consulting or Advisory Role - Novartis; Roche
Travel, Accommodations, Expenses - Novartis; Roche
 
Nana Weber-Lassalle
No Relationships to Disclose
 
Volkmar Müller
No Relationships to Disclose
 
Michael Untch
Honoraria - Amgen; AstraZeneca; Celgene; Daiichi Sankyo; Eisai Germany; Lilly; Merck Sharp & Dohme; Mundipharma; Myriad Genetics; Pfizer; Roche Pharma AG; Teva
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Mundipharma (Inst); Odonate Therapeutics; Odonate Therapeutics; Pfizer (Inst); Puma Biotechnology; Roche Pharma AG (Inst)
 
Kristina Luebbe
No Relationships to Disclose
 
Bianca Lederer
No Relationships to Disclose
 
Christian Jackisch
Consulting or Advisory Role - AstraZeneca; Genomic Health; Genomic Health; Novartis; Roche; Tesaro
Research Funding - Genomic Health (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Novartis; Roche
 
Valentina Nekljudova
No Relationships to Disclose
 
Rita K. Schmutzler
No Relationships to Disclose
 
Sibylle Loibl
Consulting or Advisory Role - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst); Teva (Inst); Vifor Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Patent Pending EP14153692.0 (Inst)
 
Andreas Schneeweiss
Honoraria - AstraZeneca; Celgene; Lilly; MSD Oncology; Novartis; Pfizer; Roche Pharma AG; Tesaro
Research Funding - Abbvie; Celgene (Inst); Molecular Partners; Roche Pharma AG (Inst)
Expert Testimony - AstraZeneca; Roche
Travel, Accommodations, Expenses - Celgene; Roche
 
Eric Hahnen
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca